“…His employer, the University Hospital Basel, has received compensation for his serving on scientific advisory boards or speaking fees from Novartis,ATI, Genzyme,Actelion, Jansen,Teva, Mitsubishi Pharma Europe, and Biogen Idec.These fees were used for funding of research. Patients affected by CDS usually suffer from periodic attacks of non-lateralized cervico-occipital pain, 11 while this patient had strictly left-sided headaches with the peak in the frontal area. He has consulted for Pfizer, Nevrocorp, Lundbeck, Zogenix, Impax, Zosano, and Dr. Reddy, and has been compensated for expert legal testimony.…”